Zubu Client Sentiment Nifty50 Report & Market Recap (Apr-28-2021)

Zubu Client Sentiment Nifty50 Report:

It is a Post Market Analysis, by which one can understand Retail trader’s sentiment and discover who was going long and short, the percentage change over time, and whether market signals are bullish or bearish

Zubu Client Sentiment Nifty50 Report Apr-28-2021)

Nifty50 retail trader data shows 51.99% of traders are net-long, while the number of retail traders net-short was 48.01%. FII’s created huge longs 8513 & huge shorts 5456, while retailers created decent longs 3602 & very huge shorts 24360.

Nifty50: 14,864 ▲ 211 (+1.4%) Sensex: 49,733 ▲ 789 (+1.6%)

The markets opened strong and continued to rise throughout the day. Of the Nifty50 stocks, 35 closed in the green. Buying interest was strongest in the financial stocks, with the Nifty Bank (+3.0%) and Nifty Financial Services (+2.8%) indices making the strongest gains. Meanwhile, Nifty Realty (-0.5%) and Nifty Pharma (-0.3%) were the top losers.

Top gainers Today’s change
Bajaj Finance ▲ 8.0%
IndusInd Bank ▲ 4.9%
Eicher Motors ▲ 4.8%

Top losers Today’s change
Britannia ▼ 2.0%
Hindalco ▼ 1.0%
Nestle India ▼ 0.9%

Bajaj Finance gains after Q4 results

The leading NBFC reported a 42% YoY jump in consolidated net profit at ₹1,347 crore for Q4 FY21. The profits grew rapidly even as the net interest income dipped by 1% to ₹4,659 crore.
The decline in loan losses and provisions by 37% YoY helped the overall profit growth. The company’s net non-performing assets (NPA) dipped to 0.75% compared to the pro forma net NPA of 1.22% in the previous quarter, indicating an improvement in asset quality. The stock surged 8% today and has gained over 13% this week.

HDFC AMC falls on market share loss

The leading mutual fund house reported assets under management worth ₹415,600 crore, up 12% YoY. Meanwhile, profit for Q4 FY21 grew 26% YoY to ₹316 crore.
Despite the growth, its market share shrank from 13.7% in March 2020 to 12.9% in the latest quarter. The stock was down 1.9% today and has corrected about 4% so far in 2021.

Syngene posts stable growth in Q4

For the latest quarter, Biocon’s contract research subsidiary reported a 13% YoY rise in revenue from operations at ₹659 crore. At ₹138 crore, profit after tax grew 15% YoY.
As per the company, the improved performance comes on account of growth in its discovery services and development services. For FY22, the company expects revenues to grow in the mid-teen range. The stock rose 1.0% today but has declined 4.6% since the start of 2021.

Anupam Rasayan hits record high on large order

Shares of the recently listed specialty chemicals company rose 5.2% intraday to its lifetime high of ₹662.5. The buying interest came after it received a ₹1,100 crore order from a multinational life sciences company.
As per the deal, Anupam Rasayan will supply life sciences-related specialty chemicals for the next five years. The stock gained 1.7% today and has returned over 21% since listing.

Closing bell

The benchmark indices have steadily inched upward this week. Today, the cues from international equities were positive. The buzz around the efforts—domestic as well as from other countries—to fight the rising cases was also strong. The market’s resilience shows that the street believes that India will be able to overcome the second wave. This time, corporate India is also much better prepared.

Meanwhile, the US Treasury yields have firmed up again—up 5% in this week—ahead of the US Fed’s interest rate announcement tonight. Reports suggest that this April, FIIs might sell the most in the last one year. In this scenario, traders must watch out for rising inflationary pressures in the Indian economy and the US treasury yields.

Comment box